Physician

Vinod Kumar, M.D.

According to 2025 Medicare claims, Vinod Kumar, M.D. (NPI: 1730142993) practices cardiology in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is SILVER SUMMIT MEDICAL CORPORATION (NPI: 1891913612; TIN: 77-0284440) and primary practice location at 93309-0631. Kumar is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,621 traditional Medicare patients, billed 6,554 HCPCS/CPT codes, and received $1,544,763 in Medicare payments. The top billing code was 36465 (Injection of chemical agent into single incompetent vein of leg using ultrasound guidance). Part D data shows 1,817 prescription claims across 329 beneficiaries totaling $196,226 in drug costs, led by Xarelto (Rivaroxaban). 2021 DME data shows 12 claims. Open Payments data shows 10 records totaling $381. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,905,739 and ending at $1,544,763. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $784 to $2,302.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,681	8,005	$3,905,739
2016	1,857	7,570	$1,628,278
2017	1,399	5,853	$831,530
2018	1,551	7,055	$2,077,104
2019	1,539	7,711	$2,628,105
2020	1,157	5,943	$1,107,155
2021	1,173	6,055	$1,967,183
2022	1,912	8,620	$1,789,679
2023	1,868	7,195	$1,742,334
2024	1,621	6,554	$1,544,763

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	892	5,498	$310,018
2016	915	5,451	$306,003
2017	651	3,629	$211,977
2018	657	3,913	$232,388
2019	626	3,989	$261,409
2020	538	3,820	$250,901
2021	522	3,038	$293,789
2022	594	2,735	$293,136
2023	486	2,362	$227,214
2024	329	1,817	$196,226

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$304
2018	N/R	N/R	N/R
2019	N/R	22	$1,387
2020	N/R	N/R	N/R
2021	N/R	12	$582
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36465	Injection of chemical agent into single incompetent vein of leg using ultrasound guidance	227	597	$1,097
93925	Ultrasound of leg arteries or artery grafts	169	171	$201
93970	Ultrasound study of arm or leg veins with compression and maneuvers	160	162	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,424	4,093	$101
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	439	495	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	124	4,513	$90,445
Eliquis	Apixaban	78	2,845	$55,436
Farxiga	Dapagliflozin Propanediol	14	540	$9,659
Clopidogrel	Clopidogrel Bisulfate	296	15,552	$2,646
Atorvastatin Calcium	Atorvastatin Calcium	281	16,417	$1,761

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$194	Kiniksa Pharmaceuticals International, plc
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$187	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vinod Kumar, M.D.?

Tedicare shows public-source Medicare data for Vinod Kumar, M.D. (NPI 1730142993), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinod Kumar, M.D. have ACO affiliation data?

Vinod Kumar, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Vinod Kumar, M.D.?

Vinod Kumar, M.D. is linked to SILVER SUMMIT MEDICAL CORPORATION (billing NPI 1891913612) in the available physician profile data.

Does Vinod Kumar, M.D. have Open Payments data?

Vinod Kumar, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.